NEULASTIM Trademark

Trademark Overview

On Tuesday, August 22, 2017, a trademark application was filed for NEULASTIM with the United States Patent and Trademark Office. The USPTO has given the NEULASTIM trademark a serial number of 87578443. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 17, 2020. This trademark is owned by Amgen Inc.. The NEULASTIM trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in stimulating white blood cell production
neulastim

General Information

Serial Number87578443
Word MarkNEULASTIM
Filing DateTuesday, August 22, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 17, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2018

Trademark Statements

Goods and Servicespharmaceutical preparations for use in stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 26, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Tuesday, February 18, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 17, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 9, 2019EXTENSION 2 GRANTED
Tuesday, April 9, 2019EXTENSION 2 FILED
Tuesday, April 9, 2019TEAS EXTENSION RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2018EXTENSION 1 GRANTED
Monday, December 10, 2018EXTENSION 1 FILED
Monday, December 10, 2018TEAS EXTENSION RECEIVED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 22, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 27, 2017NON-FINAL ACTION E-MAILED
Wednesday, September 27, 2017NON-FINAL ACTION WRITTEN
Tuesday, September 19, 2017ASSIGNED TO EXAMINER
Saturday, August 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 25, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

neulastim cell production blood white preparations stimulating pharmaceutical